Inspire Investing’s 89bio ETNB Stock Holding History

Inspire Investing’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,759	Closed	-$452K	–	1130
2025 Q3	$452K	Sell	30,759 -8,553	-22%	-$87.2K	0.04%	661
2025 Q2	$386K	Sell	39,312 -7,654	-16%	-$63.4K	0.04%	693
2025 Q1	$341K	Sell	46,966 -4,751	-9%	-$41.5K	0.04%	681
2024 Q4	$404K	Sell	51,717 -4,395	-8%	-$36.2K	0.05%	392
2024 Q3	$415K	Buy	+56,112	New	+$472K	0.04%	407

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Inspire Investing's ETNB Position: Q4 2025 in Review

Inspire Investing sold out of 89bio (ETNB) in Q4 2025, closing a stake of 30,759 shares — an estimated $452K sold.

Inspire Investing first reported a position in ETNB in Q3 2024 and held it in 5 quarters. The position peaked at $452K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Inspire Investing reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Inspire Investing sold 30,759 89bio shares in Q4 2025, an estimated $452K.
Inspire Investing first reported a position in 89bio in Q3 2024 and held it in 5 quarters.
Inspire Investing's 89bio position peaked at $452K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Inspire Investing's 13F filing for Q4 2025, filed 17 Feb 2026.